Intracardiac Flow Assessment in Cardiac Amyloidosis

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 20, 2022

Primary Completion Date

May 31, 2026

Study Completion Date

June 30, 2026

Conditions
Amyloidosis CardiacHealthy Adults
Interventions
DIAGNOSTIC_TEST

Cardiac magnetic resonance image (CMR)

A magnetic resonance imaging study for assessment of cardiac structure and intracardiac flow

DIAGNOSTIC_TEST

Transthoracic Echocardiogram (TTE)

An imaging test that uses soundwaves that cannot be heard (ultrasound) to take pictures of the heart and vessels.

DIAGNOSTIC_TEST

Six-minute Walk Test

A self-paced, test of exercise capacity performed unencouraged intensity that measures the distance that patients can walk on a flat, hard surface in a period of 6 minutes

Trial Locations (1)

55905

RECRUITING

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05379101 - Intracardiac Flow Assessment in Cardiac Amyloidosis | Biotech Hunter | Biotech Hunter